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Trifluoperazine, chlorpromazine and other drugs known to inhibit calmodulin-dependent processes are 
also known to inhibit protein kinase C. The effect of these agents on secretion evoked by known activators 
of C-kinase has been studied in human platelets loaded with the fluorescent Ca indicator, quin2 and 
preincubated with aspirin. The secretory response stimulated by phorbol ester and exogenous 
diacylglycerol, at basal levels of cytoplasmic free Ca’+, [Ca2+]i, was suppressed by trifluoperazine, 
chlorpromazine and W-7, as was the secretion evoked by collagen that occurs without a change in [Ca2+]i. 
The response to thrombin, which is accompanied byelevated [Ca2’], was barely affected. Modest elevation 
of [Ca2’], by Ca ionophore was able to overcome the inhibitory effect of these drugs on the response to 
phorbol ester, diacylglycerol, and collagen. 
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1. INTRODUCTION 
Trifluoperazine, chlorpromazine and a number 
of other antipsychotic drugs are known to inhibit 
calmodulin-dependent processes [ 11, and the in- 
hibition of a cellular function by trifluoperazine 
has been proposed as a criterion for assigning a 
role for calmodulin in the activation of that pro- 
cess [2]. However, it is also known that these drugs 
have many other activities including powerful in- 
hibitory effects on C-kinase both isolated in the 
test-tube [3,4] and in intact cells [5,6]. Activation 
of C-kinase by diacylglycerol, formed as a result of 
stimulus-evoked hydrolysis of phosphoinositides 
[7], is thought to be a key event in coupling recep- 
tor occupancy to cell activation [5]. We have 
recently shown that activators of C-kinase, ex- 
ogenous diacylglycerol and phorbol ester (TPA) 
[8], promote secretion from platelets in the absence 
of changes of cytoplasmic free calcium, [Ca2+]i, as 
can natural agonists under suitable experimental 
conditions [lo,1 11. We report here experiments in 
which trifluoperazine, chlorpromazine and W7 (a 
calmodulin antagonist also known to inhibit 
isolated C-kinase [4]) suppress this ‘calcium- 
independent’ secretion in human platelets and 
show that this inhibition is actually relieved by 
elevation of [Ca2+]i. 
2. EXPERIMENTAL 
* To whom correspondence should be addressed 
Platelet-rich plasma (PRP) was prepared from 
freshly drawn blood anticoagulated with 
acid-citrate dextrose. The cells were loaded with 
the fluorescent calcium-indicator, quin2 (Lan- 
caster Synthesis) by incubating the PRP with 20 
PM quin2 acetoxymethyl ester for 30 min at 37°C. 
The platelets were then centrifuged at 350 x g for 
20 min and resuspended in a medium containing 
145 mM NaCl, 5 mM KCI, 1 mM MgS04, 10 mM 
Hepes, 10 mM glucose (pH 7.4). 1 mM CaC12 or 
1 mM KzHzEGTA were added as required. [Ca2+]i 
was measured from the quin2 fluorescence of a 
continuously stirred suspension in a Perkin Elmer 
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MPF44A fluorimeter as in [9,10]. Excitation and 
emission wavelengths were 339 and 500 nm respec- 
tively, with 10 and 20 nm bandwidths. The release 
of ATP, as a marker for dense granule secretion, 
was continuously monitored by luciferin-lumines- 
cence in a Chronolog Lumiaggrometer. Secretion 
of 5-[‘4C]hydroxytryptamine and P-thromboglo- 
bulin (RIA, Amersham) were measured in some 
experiments as in [9, lo]. Trifluoperazine (Smith, 
Kline & French), chlorpromazine (Sigma) and W7 
were added from methanol stock solutions. 12- 
0-Tetradecanoylphorbol 13-acetate (TPA) and 
1-oleoyl-2-acetyl-glycerol (OAG) were added from 
DMSO stock. The vehicle concentration did not 
exceed 0.2% (v/v) which by itself had no obvious 
effect. For all experiments reported the cells were 
preincubated with 100 PM acetylsalicylic acid to 
block formation of prostaglandin endoperoxides 
and thromboxane AZ. 
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3. RESULTS AND DISCUSSION 
Fig. 1 shows the inhibitory effects of a near max- 
imally effective concentration, 20 PM, of 
trifluoperazine (Smith, Kline and French). The 
control responses to OAG, TPA (Sigma), collagen 
(Hormon-Chemie) and thrombin (Calbiochem) are 
similar to those in [9]. OAG, TPA and collagen 
gave a characteristic delayed secretion of ATP with 
virtually no alteration of the measured [Ca2’]i. 
This secretion is thought to be initiated by activa- 
tion of C-kinase, directly by the first 2 agents, and 
by the diacylglycerol, produced endogenously as a 
result of agonist-evoked breakdown of phospho- 
inositide, in the case of collagen. As can be seen in 
the figure, 20 PM trifluoperazine completely bloc- 
ked the secretory responses to these agents. The 
[Ca’+]i was not altered by the drug. Closely similar 
records, under the same experimental conditions, 
were obtained with chlorpromazine (Sigma) (20-40 
PM) and W7 (60pM). We also confirmed that tri- 
fluoperazine blocked the TPA-evoked secretion of 
another constituent of the dense granule, 5-hyd- 
roxytryptamine, and a marker for a-granule exo- 
cytosis, ,&thromboglobulin. The apparent E&c 
for trifluoperazine and chlorpromazine to inhibit 
TPA evoked secretion was 9 PM and 14 FM respec- 
tively. These values are slightly lower than those 
reported for these drugs acting on isolated C 
kinase [3,4]. The EGO for W7 was 25 PM. 
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Fig. 1. Effects of 20 gM trifluoperazine on responses to 
60ag/ml OAG, 20 nM TPA, 20pg/ml collagen and 0.5 
U/ml thrombin. The upper trace of each pair shows the 
secretion of ATP, expressed as a % of the maximum 
released by thrombin. The lower trace shows [Ca”], 
reported by fluorescence of intracellular quin2. The 
addition of trifluoperazine (or chlorpromazine) 
produced a steep increase in signal due to its native 
fluorescence. This increase merely added to the cell 
autofluorescence and has been substracted from retraced 
records. In (a) and (b) 1 mM EGTA was added and in 
(c) and (d) 1 mM CaC12. In other experiments we 
examined the responses to OAG and TPA in 1 mM Ca 
medium and obtained results like those shown here. 
Comparable results were also found in cells prepared 
similarly, but not loaded with quin2. 
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The results shown in fig. lD, 2 suggest hat these 
drugs were not inhibiting secretion by generalised 
toxic or non-specific effects. First, at concentra- 
tions that blocked the secretory responses to 
diacylglycerol, TPA and collagen, these drugs had 
only a small effect on either the increase in [Ca”], 
or the secretion evoked by thrombin. This is shown 
for trifluoperazine in fig. 1D and closely similar 
results were obtained with chlorpromazine and 
W7. Second, the addition of low concentrations of 
calcium ionophore, that increased [Ca*+]i to 
about 700 nM, below that threshold for ]Ca*+]; 
alone to evoke secretion, could largely overcome 
the inhibitory effects of trifluoperazine, chlor- 
promazine and W7. This effect is illustrated in fig. 
2. In panel A application of 40 nM A23187 to 
chloropromazine-treated cells raised [Ca*+]i to ap- 
proximately 700 nM without causing any secretion. 
(This elevation of [Ca*‘]i equally produces no 
secretion in cells not inhibited with chlorproma- 
zine.) Subsequent application of diacylglycerol, 
which by itself is quite ineffective in chlorproma- 
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Fig. 2. Experimental conditions were as stated in the 
legend to fig. 1. The cells were pretreated with 30 pM 
chlorpromazine. In (a) 60 gg/ml OAG was applied 
followed by 40 nM A23 187 (Calbiochem) added from 20 
PM methanol stock. In (b) these agents were applied in 
reverse order. The [Ca*+]; records are cut short because 
the fluorescence signal is spuriously lost as the cells 
aggregate [8]. 
zine-treated cells (fig. 23) now evokes a substantial 
secretory response. In fig. 2B diacylglycerol failed 
to elicit a response in the chlorpromazine-treated 
cells. A normally subthreshold elevation of [Ca2+Ji 
caused by subsequent addition of A23187 now 
stimulates secretion. Again, very similar results 
were obtained with the other drugs, trifluoperazine 
and W7, and also when TPA or collagen was used 
as the stimulus. The secretion evoked from the 
drug-treated cells by thrombin, or by a subthreshold 
increase in [Ca2+]i together with diacylglycerol or 
TPA, may reflect the ability of calcium to counter- 
act the inhibition of C-kinase, as has been seen in 
experiments with the isolated enzyme [3,4]. 
The data suggest hat the most prominent effect 
of this group of drugs on platelets may reflect their 
interference with C-kinase rather than with 
calmodulin-dependent processes. The finding that 
the response to collagen, in aspirin-treated cells, is 
inhibited in the same manner as the response to 
known activators of C-kinase supports our 
previous arguments [8] that the response to col- 
lagen under these conditions reflects activation of 
this enzyme independent of changes in [Ca2+]i. It 
is interesting to note that in the earliest reports of 
inhibition of platelet action by chlorpromazine the 
agonist apparently most susceptible was collagen 
fl2], and that in a more recent study trifl uopera- 
zine appeared to be more effective in inhibiting 
phosphorylation of the 40 kDa substrate of C- 
kinase than the 20 kDa substrate of calmodulin- 
dependent protein kinase [6]. 
It seems that drugs often used as probes for 
calmodulin actions can be very effective against 
processes in intact cells mediated by C-kinase even 
though the activity of C-kinase is apparently not 
influenced by calmodulin 1151. Indeed, the in- 
hibitory effects of these agents were seen best at 
basal [Ca*+]i and were markedly counteracted by 
elevation of [Ca’+]i whether by an agonist, throm- 
bin, or by calcium ionophores. Our results point 
particularly clearly to the hazards of deducing 
from the observation that trifluoperazine, W7 or 
related compounds inhibit a cellular function, that 
this function is mediated by Ca-calmodulin (e.g. 
[ 12,16,17,18]. In particular the present results sug- 
gest the need for reappraisal of those studies in 
which ‘calmodulin antagonists’ were found to in- 
hibit secretion, and those findings taken to con- 
firm the role of calcium and ~almodulin in the trig- 
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gering of secretory exocytosis. Such experiments 
may well prove to be pointers to the importance of 
C-kinase in initiating exocytosis. The concentra- 
tions of trifluoperazine and/or chlorpromazine 
needed to inhibit platelet secretion are about an 
order of magnitude greater than high therapeutic 
levels, but the possibility exists that part of the an- 
tipsychotic action of these drugs might be due to 
interference with C-kinase at critical sites in the 
brain. 
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